Property	Value
Status
Version
Ad File
Disable Ads Flag
Environment
Moat Init
Moat Ready
Contextual Ready
Contextual URL
Contextual Initial Segments
Contextual Used Segments
AdUnit
SubAdUnit
Custom Targeting
Ad Events
Invalid Ad Sizes

Robert T. Brodell MD, FAAD Editor-in-Chief

See All Experts

featured

Published in Dermatology

Journal Scan / Research · November 11, 2024

Efficacy and Safety of Upadacitinib vs Dupilumab in Adults and Adolescents With Moderate to Severe Atopic Dermatitis

The British Journal of Dermatology

Save Recommend

Sign in to PracticeUpdate

Only registered members have full access to PracticeUpdate content.

Not a member?

Join for free

Efficacy of Treatment With Upadacitinib in Adolescents With Moderate to Severe Atopic Dermatitis Through 76 Weeks

The British Journal of Dermatology

Efficacy and Safety of Upadacitinib vs Dupilumab in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis: Week 16 results of an Open-label, Randomized, Efficacy Assessor-Blinded Head-to-Head Phase 3b/4 Study (Level Up)

Br J Dermatol 2024 Oct 23;[EPub Ahead of Print], JI Silverberg, CG Bunick, HC Hong, P Mendes-Bastos, L Stein Gold, A Costanzo, N Ibrahim, C Sancho, X Wu, Y Han, G Levy, K Altman, B Calimlim, K Eyerich

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Efficacy and Safety of Upadacitinib vs Dupilumab in Adults and Adolescents With Moderate to Severe Atopic Dermatitis

Additional Info

Efficacy and Safety of Upadacitinib vs Dupilumab in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis: Week 16 results of an Open-label, Randomized, Efficacy Assessor-Blinded Head-to-Head Phase 3b/4 Study (Level Up)

Further Reading

Safety of Biologic Use During Pregnancy and Breastfeeding in Dermatology

Impact of Clinical Information on Melanocytic Skin Lesion Pathology Diagnosis

Local Recurrence, Metastasis, and Mortality Rates Among Patients With Thin and In Situ Melanomas

Suicidal and Self-Injurious Behaviors Among Patients With Psoriasis or Psoriatic Arthritis Treated With Biologics

Association Between Treatment With Biologics and Cardiovascular Comorbidities in Patients With Psoriasis

Efficacy and Safety of Upadacitinib vs Dupilumab in Adults and Adolescents With Moderate to Severe Atopic Dermatitis

Efficacy of Treatment With Upadacitinib in Adolescents With Moderate to Severe Atopic Dermatitis Through 76 Weeks

Non-SCORTEN Predictors of Mortality Among Patients With SJS/TEN

Risk Factors for Subclinical Spread in Patients With Melanoma In Situ and Invasive Melanoma

Outcomes of Dermoscopic vs Naked-Eye Evaluation of Surgical Margins in Patients With Nonmelanoma Skin Cancer Undergoing Mohs Micrographic Surgery

Effect of Treatment With Ritlecitinib on Patient-Reported Hair Loss Among Patients With Alopecia Areata

Recently Updated